Zemcelpro
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Zemcelpro, covering 2025-06-20 to 2026-07-16. Get the full timeline:
Most recent: EMA Authorised: Zemcelpro (allogeneic umbilical cord-derived CD34- cells, non-expanded;dorocubicel) — Cordex Biologics International Limited